What is I3LUNG
I3LUNG is a European project funded under the framework of the Horizon Europe (HEurope) call “Ensuring access to innovative, sustainable and high-quality health care”. Our consortium gathers 16 partners with different expertise located worldwide, with the common goal of providing better assistance and individualize treatment for patients affected by metastatic lung cancer.
For Patients
In the video below the project explained by Anne-Marie Baird, President of Lung Cancer Europe (LuCE) (one of the partners of the I3LUNG).
“We are excited to start this project which is envisioned to both generate novel therapeutic guidelines for clinical practice in lung cancer and support the growth of digital diagnostic tools in the European industry. (I3LUNG Partners)„
Find out the most relevant news on the latest advancements in lung cancer!
News
December, 3 2024
The I3LUNG project and the Metropolitan Hospital have been awarded the Gold Prize at the prestigious Healthcare Business Awards, recognizing […]
News
November, 22 2024
At the recent VIII Thoracic Oncology Conference in Bari, the I3LUNG project PI, Arsela Prelaj, took the stage with her […]
News
October, 28 2024
Last Friday, MEDSIR’s office hosted a meeting for the I3LUNG partners: Vall d’Hebron Institute of Oncology (VHIO), Universitätsklinikum Hamburg Eppendorf, […]